How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos

How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos

Lorlatinib for ALK+metastatic non-small cell lung cancer.Подробнее

Lorlatinib for ALK+metastatic non-small cell lung cancer.

Uncommon EGFR mutations in metastatic non-small cell lung cancer.Подробнее

Uncommon EGFR mutations in metastatic non-small cell lung cancer.

Treatment options for metastatic Non-small cell lung cancer with actionable mutations in 1LПодробнее

Treatment options for metastatic Non-small cell lung cancer with actionable mutations in 1L

Dr Balazs Halmos: CNS metastases in EGFRm mNSCLCПодробнее

Dr Balazs Halmos: CNS metastases in EGFRm mNSCLC

Dr. Halmos on Actionable Biomarkers in NSCLCПодробнее

Dr. Halmos on Actionable Biomarkers in NSCLC

Dr. Halmos on Detecting Actionable Mutations in Patients With Lung CancerПодробнее

Dr. Halmos on Detecting Actionable Mutations in Patients With Lung Cancer

Dr. Halmos on MET Mutations in Patients With NSCLCПодробнее

Dr. Halmos on MET Mutations in Patients With NSCLC